Apolipoprotein E polymorphism in ischemic cerebrovascular diseases and vascular dementia patients in Taiwan

Neuroepidemiology

Volumn 23, Issue 3, 2004, Pages 129-134

  Lin, Hsiu Fen ^a   Lai, Chiou Lian ^a   Tai, Chih Ta ^a   Lin, Ruey Tay ^a   Liu, Ching Kuan ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Age; Apolipoprotein E; Cerebrovascular diseases; Vascular dementia

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; ALLELE; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DEMOGRAPHY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; PROTEIN POLYMORPHISM; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; TAIWAN;

AGED; AGED, 80 AND OVER; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CEREBRAL INFARCTION; DEMENTIA, MULTI-INFARCT; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; GENOTYPE; HETEROZYGOTE DETECTION; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK; TAIWAN;

EID: 1842851818     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000075956     Document Type: Article

References (43)

1. Davignon J, Gregg RE, Sing CF: Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988;8:1-21.
2. Nathan BP, Bellosta S, Sanan DA, Weisgraber KH, Mahley RW, Pitas RE: Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 1994;264:850-852.
3. Dickson DW, Roy N, Graff-Radford D, et al: Apolipoprotein-E genotype influences amyloid deposition and limbic neurofibrillary degeneration, but not Lewy body or vascular pathologies in postmortem brains. Neurology 1999;52:A562-A563.
4. Hixson JE: Apolipoprotein E polymorphisms affect atherosclerosis in young males. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Arterioscler Thromb 1991;11:1237-1244.
5. Cattin L, Fisicaro M, Tonizzo M, et al: Polymorphism of the apolipoprotein E gene and early carotid atherosclerosis defined by ultrasonography in asymptomatic adults. Arterioscler Thromb Vasc Biol 1997;17:91-94.
6. Wilson PW, Schaefer EJ, Larson MG, Ordovas JM: Apolipoprotein E alleles and risk of coronary disease. A meta-analysis. Arterioscler Thromb Vasc Biol 1996;16:1250-1255.
7. Katzel LI, Fleg JL, Paidi M, Ragoobarsingh N, Goldberg AP: ApoE4 polymorphism increases the risk for exercise-induced silent myocardial ischemia in older men. Arterioscler Thromb 1993;13:1495-1500.
8. Kuusisto J, Koivisto K, Kervinen K, et al: Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: Population based study. BMJ 1994;309:636-638.
9. Treves TA, Bornstein NM, Chapman J, et al: APOE-epsilon 4 in patients with Alzheimer disease and vascular dementia. Alzheimer Dis Assoc Disord 1996;10:189-191.
10. Hofman A, Ott A, Breteler MM, et al: Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet 1997;349:151-154.
11. Pedro-Botet J, Senti M, Nogues X, et al: Lipoprotein and apolipoprotein profile in men with ischemic stroke: Role of lipoprotein(a), triglyceride-rich lipoproteins, and apolipoprotein E polymorphism. Stroke 1992;23:1556-1562.
12. Couderc R, Mahieux F, Bailleul S, Fenelon G, Mary R, Fermanian J: Prevalence of apolipoprotein E phenotypes in ischemic cerebrovascular disease: A case-control study. Stroke 1993;24:661-664.
13. Schmidt R, Schmidt H, Fazekas F, et al: Apolipoprotein E polymorphism and silent microangiopathy-related cerebral damage. Results of the Austrian Stroke Prevention Study. Stroke 1997;28:951-956.
14. Ji Y, Urakami K, Adachi Y, Maeda M, Isoe K, Nakashima K: Apolipoprotein E polymorphism in patients with Alzheimer's disease, vascular dementia and ischemic cerebrovascular disease. Dement Geriatr Cogn Disord 1998;9:243-245.
15. Kuusisto J, Mykkanen L, Kervinen K, Kesaniemi YA, Laakso M: Apolipoprotein E4 phenotype is not an important risk factor for coronary heart disease or stroke in elderly subjects. Arterioscler Thromb Vasc Biol 1995;15:1280-1286.
16. Zhu L, Fratiglioni L, Guo Z, et al: Incidence of dementia in relation to stroke and the apolipoprotein E epsilon4 allele in the very old: Findings from a population-based longitudinal study. Stroke 2000;31:53-60.
17. Basun H, Corder EH, Guo Z, et al: Apolipoprotein E polymorphism and stroke in a population sample aged 75 years or more. Stroke 1996;27:1310-1315.
18. Lin RT, Lai CL, Tai CT, Liu CK, Yen YY, Howng SL: Prevalence and subtypes of dementia in southern Taiwan: Impact of age, sex, education, and urbanization. J Neurol Sci 1998;160:67-75.
19. Liu CK, Lin RT, Chen YF, Tai CT, Yen YY, Howng SL: Prevalence of dementia in an urban area in Taiwan. J Formos Med Assoc 1996;95:762-768.
20. De Carli C, Reed T, Miller BL, Wolf PA, Swan GE, Carmelli D: Impact of apolipoprotein E epsilon4 and vascular disease on brain morphology in men from the NHLBI twin study. Stroke 1999;30:1548-1553.
21. Pirttila T, Lehtimaki T, Rinne J, Mattila K, Frey H, Nikkari T: The frequency of apolipoprotein E4 allele is not increased in patients with probable vascular dementia. Acta Neurol Scand 1996;93:352-354.
22. Stengard JH, Pekkanen J, Sulkava R, Ehnholm C, Erkinjuntti T, Nissinen A: Apolipoprotein E polymorphism, Alzheimer's disease and vascular dementia among elderly Finnish men. Acta Neurol Scand 1995;92:297-298.
23. Nakayama S, Kuzuhara S: Apolipoprotein E phenotypes in healthy normal controls and demented subjects with Alzheimer's disease and vascular dementia in Mie Prefecture of Japan. Psychiatry Clin Neurosci 1999;53:643-648.
24. Liu HC, Hong CJ, Wang SJ, et al: ApoE genotype in relation to AD and cholesterol: A study of 2,326 Chinese adults. Neurology 1999;53:962-966.
25. Kao JT, Tsai KS, Chang CJ, Huang PC: The effects of apolipoprotein E polymorphism on the distribution of lipids and lipoproteins in the Chinese population. Atherosclerosis 1995;114:55-59.
26. Wenham PR, Price PH, Blundell A: Apolipoprotein E genotyping by one gate PCR. Lancet 1991;337:1158-1159.
27. Slooter AJ, Bots ML, Havekes LM, et al: Apolipoprotein E and carotid artery atherosclerosis: The Rotterdam study. Stroke 2001;32:1947-1952.
28. Molero AE, Pino-Ramirez G, Maestre GE: Modulation by age and gender of risk for Alzheimer's disease and vascular dementia associated with the apolipoprotein E-epsilon4 allele in Latin Americans: Findings from the Maracaibo Aging Study. Neurosci Lett 2001;307:5-8.
29. Schachter F, Faure-Delanef L, Guenot F, et al: Genetic associations with human longevity at the Apo E and ACE loci. Nat Genet 1994;6:29-32.
30. Katzman R, Zhang MY, Chen PJ, et al: Effects of apolipoprotein E on dementia and aging in the Shanghai Survey of Dementia. Neurology 1997;49:779-785.
31. Yang J, Feng G, Zhang J, et al: Is ApoE gene risk factor for vascular dementia in Han Chinese? Int J Mol Med 2001;7:217-219.
32. Zhang JG, Yang JG, Lin ZX, et al: Apolipoprotein E epsilon4 allele is a risk factor for lateonset Alzheimer's disease and vascular dementia in Han Chinese. Int J Geriatr Psychiatry 2001;16:438-439.
33. Kawamata J, Tanaka S, Shimohama S, Ueda K, Kimura J: Apolipoprotein E polymorphism in Japanese patients with Alzheimer's disease or vascular dementia. J Neurol Neurosurg Psychiatry 1994;57:1414-1416.
34. Higuchi S, Arai H, Nakagawa T, Muramatsu T, Sasaki H, Trojanowski JQ: The apolipoprotein E gene in Binswanger's disease and vascular dementia. Clin Genet 1996;50:459-461.
35. Tang MX, Maestre G, Tsai WY, et al: Effect of age, ethnicity, and head injury on the association between APOE genotypes and Alzheimer's disease. Ann NY Acad Sci 1996;802:6-15.
36. Farrer LA, Cupples LA, Haines JL, et al: Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 1997;278:1349-1356.
37. Reed DM: The paradox of high risk of stroke in populations with low risk of coronary heart disease. Am J Epidemiol 1990;131:579-588.
38. Liu L, Mizushima S, Ikeda K, et al: Comparative studies of diet-related factors and blood pressure among Chinese and Japanese: Results from the China-Japan Cooperative Research of the WHO-CARDIAC Study - Cardiovascular disease and alimentary comparison. Hypertens Res 2000;23:413-420.
39. Ueshima H, Zhang XH, Choudhury SR: Epidemiology of hypertension in China and Japan. J Hum Hypertens 2000;14:765-769.
40. Skoog I, Hesse C, Aevarsson O, et al: A population study of apoE genotype at the age of 85: Relation to dementia, cerebrovascular disease, and mortality. J Neurol Neurosurg Psychiatry 1998;64:37-43.
41. Bergem AL, Engedal K, Kringlen E: The role of heredity in late-onset Alzheimer disease and vascular dementia: A twin study. Arch Gen Psychiatry 1997;54:264-270.
42. Gupta SR, Naheedy MH, Young JC, Ghobrial M, Rubino FA, Hindo W: Periventricular white matter changes and dementia: Clinical, neuropsychological, radiological, and pathological correlation. Arch Neurol 1988;45:637-641.
43. Lin RT, Lai CL, Tai CT, Liu CK, Howng SL: Cranial computed tomography in ischemic stroke patients with and without dementia - A prospective study. Kaohsiung J Med Sci 1998;14:203-211.